Kera Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Kera Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Buy	+677	New	+$380K	0.03%	429

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kera Capital Partners's IDXX Position: Q2 2026 in Review

Kera Capital Partners opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 677 shares worth $356K. The stake represents 0.03% of the portfolio and ranks #429 among its holdings.

1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Kera Capital Partners held 677 shares of Idexx Laboratories worth $356K as of Q2 2026.
Idexx Laboratories was a new Kera Capital Partners position in Q2 2026.
Idexx Laboratories made up 0.03% of Kera Capital Partners's portfolio in Q2 2026, its #429 holding.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.